JPRN-UMIN000001323
Completed
未知
Open-label cross-over study to evaluate the amount of residual inhaled corticosteroid (hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) and fluticasone propionate dry powder inhaler (FP-DPI)) in the mouths of elderly asthmatic patients after each inhalation - The evaluation of the amount of residual inhaled corticosteroid (HFA-BDP and FP-DPI) in the mouths of elderly asthmatic patients after each inhalation.
JA Gifu Kouseiren Tohno-Kousei Hospital0 sites22 target enrollmentAugust 25, 2008
ConditionsAsthma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- JA Gifu Kouseiren Tohno-Kousei Hospital
- Enrollment
- 22
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)any hypersensitivity history for steroids, 2\)under treatment with oral steroids, 3\)under desensitization or non\-specific therapy which is newly initiated within 6 months before this study, 4\)other coexisting chronic respiratory diseases except for chronic obstructive pulmonary disease (COPD), 5\)severe hepatic or renal disease, heart failure, hematologic diseases, or other severe co\-morbid disease, 6\)under treatment for chronic respiratory infectious diseases, 7\)expectation of poor drug compliance, 8\)Inappropriate patients from the doctor's viewpoint
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An open label, crossover study to investigate the safety and tolerability of Sifrol® (pramipexole) (Boehringer Ingelheim) prolonged release tablets in order to establish the maximum tolerable dose and to assess bioequivalence of Pramipexole prolonged release tablets (Synthon B.V.) compared to Sifrol® prolonged release tablets (Boehringer Ingelheim) in healthy subjects in steady-state conditionsparkinson's disease10042258NL-OMON36833Synthon B.V52
Completed
Not Applicable
A study of two different formulations of buprenorphine in healthy volunteers.PainAddictionACTRN12617000002381iX Biopharma Pty Ltd14
Recruiting
Not Applicable
Vitamin D3 clinicaltrial I in healthy adult volunteersNot ApplicableKCT0000411Dream Pharma36
Recruiting
Not Applicable
Ibandronate clinicaltrial Phase I in healthy adult volunteersNot ApplicableKCT0000191Dream Pharma84
Completed
Phase 3
An open-label randomised cross-over study to evaluate the albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetesdiabetesDiabetes Mellitus10012653NL-OMON46820Martini Ziekenhuis20